The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. (Q52726729)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 January 2018
edit
Language Label Description Also known as
English
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.
scientific article published on 8 January 2018

    Statements

    The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit